Silica Carrier for Pesticides: Absorption Capacity, Flowability and Grade Selection

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Fumed Silica 200 m²/g: Properties, Typical Uses and Comparable Grades
  • Keywords: EMC filler
  • Published: 2026-11-20 05:40:25
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Mesoporous silica nanoparticles (MSNs) are recognized as a prime example of nanotechnology applied in the biomedical field, owing to their readily tunable structure and composition, various surface functionalization properties, and excellent biocompatibility. Over the past two decades, researchers have developed a wide range of MSNs-based nanoplatforms through careful design and controlled preparation approaches, demonstrating their adaptability to diverse biomedical application scenarios. With the continuous breakthroughs of MSNs in the fields of biosensing, disease diagnosis and treatment, tissue engineering, etc., MSNs are steadily moving from basic research to clinical trials. In this review, we supply a detailed summary of MSNs in the biomedical field, beginning with a comprehensive overview of their expansion history. We then discuss the types of MSNs-based nanostructured architectures, along with the classification of MSNs-based nanocomposites according to the elements existed in diverse inorganic functional factors. Subsequently, we summarize the primary purposes of surface-functionalized modifications of MSNs. In the following, we examine the biomedical applications of MSNs, and highlight the MSNs-based targeted therapeutic modalities currently developed. Given the importance of clinical translation, we also summarize the progress of MSNs in clinical trials. Lastly, we take a perspective on the future direction and remaining difficulties of MSNs in the biomedical field.

Silica Sol Manufacturer: Product Types, Quality Control and How to Choose

Silica Supplier Europe: Major Producers, Regulations and Sourcing Options
Thierry, B. et al. Electrostatic self-assembly of PEG copolymers onto porous silica nanoparticles. Langmuir 24, 8143-8150 (2008). Post CAS PubMed Google Scholar
Fused Silica CAS 60676-86-0: Identification, Properties and Safety Data
Does Silicon Dioxide Conduct Electricity? Why SiO₂ Is an Insulator
Overview of MSNs
Quartz Sand Supplier Egypt: Quality, Grades and Export Options

Respirable Crystalline Silica OSHA Standard: Exposure Limits and Compliance Requirements

What is silica (SiO₂)?

silane coupling agent

What is the difference between fumed silica and precipitated silica?

porous silica

What drives silica raw material prices?

silica gel column chromatography The pathway of administration of MSN during treatment contains oral, inhalation, intravenous, intramuscular and intraperitoneal injections. Regardless of the administration approach, it is expected that the MSNs will be maximally enriched at the lesion site. However, in those delivery systems, MSNs-based formulations tend to distribute throughout the body. 312, 313 Some studies have shown that MSNs accumulate largely in the liver and spleen, 312, 314, 315 and that the high concentration of MSNs at these normal organ tissues not only severely reduces the therapeutic efficacy of MSNs-based formulations, but also induces some potentially toxic influences on the RES. Consequently, boosting the active targeting skill of MSNs has substantial implications for facilitating preclinical studies of MSNs-based therapeutic system.

Cite this article: Silica Raw Materials News. "Custom Silica: Tailoring Particle Size, Surface Treatment and Purity to Your Application ." Published 2026-11-20 05:40:25. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.